FDA Approval: AMBELVIST (GADOQUATRANE) — Type 1 - New Molecular Entity
Policy FDA-NDA219627 · Radiology
HighAmbelvist (Gadoquatrane) is approved for intravenous administration, indicating that billing will follow the Part B pathway. As it is designated as an orphan drug, it may qualify for special considera
View alertLCD L33459: Computerized Axial Tomography (CT), Thorax — Palmetto GBA
Policy LCD-L33459 · Radiology
HighThe finalized LCD L33459 outlines billing guidelines for Computerized Axial Tomography (CT) of the thorax, effective 06/11/2026. Providers in the impacted states should review the guidelines thoroughl
View alertProposed LCD DL40289: Non-invasive Arterial Duplex Ultrasound of the Upper and Lower Extremities — First Coast
Policy LCD-DL40289 · Radiology
HighThe proposed LCD for non-invasive arterial duplex ultrasound of the upper and lower extremities may lead to supports compliance with updated rates for providers in the relevant specialties. This could i
View alertProposed LCD DL40332: Automated Detection and Quantification of Brain MRIs — NGS
Policy LCD-DL40332 · Radiology
HighThe proposed LCD for automated detection and quantification of brain MRIs could streamline the billing process for radiologists and improve reimbursement rates for these services. By standardizing eva
View alert